As of September 2024, Nectar Lifesciences has a market cap of $140.14M. This makes Nectar Lifesciences the world's 19411th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $98.25M | 14.31% |
2023 | $85.95M | 30.96% |
2022 | $65.63M | -8.40% |
2021 | $71.65M | 12.13% |
2020 | $63.90M | 96.71% |
2019 | $32.48M | -41.16% |
2018 | $55.21M | -46.98% |
2017 | $104.13M | 18.03% |
2016 | $88.22M | -39.06% |
2015 | $144.77M | 54.27% |
2014 | $93.84M | 88.71% |
2013 | $49.73M | -11.43% |
2012 | $56.14M | 26.89% |
2011 | $44.25M | -46.96% |
2010 | $83.41M | -4.15% |
2009 | $87.02M | 74.53% |
2008 | $49.86M | -37.72% |
2007 | $80.06M | 84.96% |
2006 | $43.28M | -25.27% |
2005 | $57.92M | - |